Not a sourcing thread. Exemestane, three years, and what I can and cannot conclude from my own experience.

Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.

If you need three other compounds to notice the first one, you have not tested the first one.

I would rather have a narrow conclusion and be right than a broad one and be interesting.

What the aromatase inhibitor class does pharmacologically does not require the subjective effect to be large to be real.

How do you separate the compound effect from the routine around it?